Nonalcoholic steatohepatitis (NASH), the progressive form of nonalcoholic fatty liver disease, has superseded hepatitis C as the main cause of cirrhosis and the main reason for liver transplantatio. Showing 1-25: ICD-10-CM Diagnosis Code K70. 2 - other international versions of ICD-10 K74. 8 ICD-9 Billable. 31 [convert to ICD-9-CM] Alcoholic cirrhosis of liver with ascites. 0)Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal serum aminotransferase levels in both developed and developing countries. with a diagnosis of hepatic steatosis confirmed by biopsy when available. K70 Alcoholic liver disease. Zoli M, Melchionda N: Metformin in non-alcoholic steatohepatitis. Afdhal discusses evidence-based management of nonalcoholic fatty liver disease, including differentiation between simple steatosis and nonalcoholic steatohepatitis. 2298. At present, clinical coding of this diagnosis requires the combination of two imprecise codes: K74. Although noninvasive clinical scores and image-based diagnosis. 573. Methods Annual deaths and age-standardized death rates (ASDR) for NALC from 1990 to 2019 were collected from the. 8 should only be used for claims with a date of service on or before September 30, 2015. 6%). (fatty inflammation of liver), steatohepatitis nonalcoholic, steatosis of liver, and yellow atrophy of liver chronic. Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronic; Applies To. Nonalcoholic steatohepatitis (NASH) - instead, use code K75. Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. 81), whereas the ICD-9 codes are more ambiguous and could represent either NAFL or NASH. Bethesda, MD 20892–3570 . e. x) and insulin resistance (ICD-9 code 277. – ICD-10 diagnosis codes (K74. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 01 Hepatic fibrosis, early fibrosis K74. 1, V02. codes reported an incidence rate for NAFLD of 29 per 100,000 person-years. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. Patients diagnosed with other liver diseases with any ICD‐9 codes for viral, alcoholic, or cholestatic liver disease were excluded from the clinical NAFLD group. 26 billion by 2028 from $1. Helpline 1-800-465-4837. The 2019 Standards of Medical Care in Diabetes suggested that patients with nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. | ICD-10 from 2011 - 2016 K75. The 2024 edition of ICD-10-CM K70. This is the American ICD-10-CM version of K74. Search online 72,000+ ICD-10 codes by number, disease, injury, drug, or keyword. 0–571. 1 is a non-billable code. Non-alcoholic steatohepatitis (NASH) is a condition that falls under the umbrella of non-alcoholic fatty liver diseases (NAFLD), which are caused by fat buildup in the. It affects an estimated 20% of the general population, based on cohort studies of varying size and heterogeneous selection. Liver biopsy is the gold standard for diagnosis and prognosis. Likely NASH patients can be counted in ≥ 1 pattern, possible NASH patients can. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in shrsp5/dmcr rat model. NAFLD/NASH cirrhosis may also attract code K74. Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. ) and global population. 8: Micrograph of. NAFLD is the most common liver disease in the U. e. 81) Hierarchy Tree View ICD-10; YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY. 1 - other international versions of ICD-10 K70. Non-Billable On/After Oct 1/2015. 500 results found. Clinics for Diagnosis. (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver. Nonalcohol-associated fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis in the absence of excessive alcohol consumption. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. ICD-9-CM 571. K76 Other diseases of liver. This applies to chronic yellow atrophy (liver) and fatty liver without mention of alcohol. Hepatopulmonary syndrome. Some patients with NAFLD progress to nonalcoholic. 0 became effective on October 1, 2018. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. Below are some of the ICD-10-CM Diagnosis codes that could potentially be assigned based on provider documentation. [email protected] ‘Fatty (change of) liver, not elsewhere classified (non-alcoholic fatty liver disease)’. 63 billion in 2021; it is expected to register a CAGR of 47. Nonalcoholic fatty liver disease (NAFLD) Type 1 Excludes. Choose Language. The presence of cirrhosis was determined based on results of imaging or ICD-9 or 10 codes. Chronic yellow atrophy (liver) Fatty liver, without mention. 334 obeticholic acid improves experimental non‐invasive markers of non‐alcoholic steatohepatitis and advanced fibrosis; results of a secondary analysis from the month‐18 interim analysis of the REGENERATE study. No significant differences were observed regarding metabolic syndrome, type 2 diabetes mellitus, hypertension, dyslipidemia, rs662 polymorphism allele frequencies,. 02 [convert to ICD-9-CM] Hepatic fibrosis, advanced fibrosis. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. 11 may differ. Methods: We performed a prospective study on patients with. Quantitative results of 10 biochemicals in combination with age, gender, height, and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0. However, the performance of noninvasive clinical models/scores and plasma biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) and advanced fibrosis has not been. Nonalcoholic fatty liver disease is a manifestation of an abnormality of metabolism within the liver. Other inflammatory liver diseases. Abstract. alcoholic liver disease (. poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4); alcoholic liver disease (K70. in; a Local Coverage Determination (LCD) policy or Article ID; or a CPT/HCPCS procedure/billing code or an ICD-10-CM diagnosis code. Type 2 Excludes. 60 - other international versions of ICD-10 K74. The field of nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH), has, despite the challenges of the coronavirus disease 2019 (COVID-19) pandemic. This Perspective summarizes. The control group was. Lancet Gastroenterol Hepatol. ContentsK75. All patients should have had an abdominal imaging study to exclude biliary obstruction and liver diseases such as hepatocellular carcinoma and liver abscess. The new codes are as follows:K74. ICD-10-CM Diagnosis Code K70. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ or K76. ICD-10-CM Coding Rules. Other Codes Used Similar Conditions. 8 should only be used for claims with a date of service on or before September 30, 2015. Background Although non-alcoholic fatty liver disease (NAFLD) is linked to inflammation, whether an inflammatory diet increases the risk of NAFLD is unclear. Clinical background. MRE-based NASH score for diagnosis of. ICD-9 Code ICD-9 Description; K75. S. Obesity may be represented by ICD-10-AM codes under the E66 code block or by the chronic conditionICD-10-CM Diagnosis Code K75. ICD-10-CM Code K70. Explore the Nonalcoholic Steatohepatitis (NASH) complications. ICD-10-CM Diagnosis Code K71. NAFLD has a histologic spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. All tests were performed within a maximum of 72 h of each other, with the notable exception of the hepatic biopsy, which was performed within the previous 6-months. The use of ICD‐9 codes underestimates prevalent NAFLD because the vast majority of NAFLD is subclinical. 0) codes in the absence of any diagnosis codes for other common causes of chronic liver disease . 8. 1 contain annotation back-references that may be applicable to K70. 2014. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. 9 million patients in 2030 (~1/3 of the. Showing 1-25: ICD-10-CM Diagnosis Code K70. K75 Other inflammatory liver diseases. (2022) How To Code Chronic Constipation ICD 10 – List With Codes & Guidelines. 81. Although a similar. This is the American ICD-10-CM version of K75 - other international versions of ICD-10 K75 may differ. There are more than 20 million NAFLD patients in Japan, and it is feared that this number will increase in the future []. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as. Yellowing of the skin and eyes ( jaundice) Spider-like blood vessels just beneath your skin’s surface. An UpToDate review on "Epidemiology, clinical features, and diagnosis of nonalcoholic steatohepatitis" (Sheth and Chopra, 2012) states that "A potentially useful non-invasive method for. 8) is used infrequently in Swedish healthcare, and we did not intend to. K74. (protocol code no. (1,2). Explore these free. 71% NASH in OSA patients: 2% NASH in non-OSA patients: 0. 60 may differ. Evidence of NASH included either a NASH ICD -10 diagnosis code or a NASH NLP affirmation. Scarring of the liver is a potentially life-threatening condition called. 0 may differ. 4 Chronic hepatitis. 41 became effective on October 1, 2023. A recent analysis of studies involving more than 8. 7. ICD-10-CM Coding Rules. 01-E. K72 Hepatic failure, not elsewhere classified. K75. The following code (s) above K74. Nonalcoholic fatty liver disease (NAFLD) is today the most common cause of chronic liver disease and second only to viral hepatitis as a cause of liver transplantation in the U. [4] [5] [8] NAFL is less dangerous than NASH and usually does not progress towards it, [4] but this progression may eventually lead to complications such as cirrhosis , liver. This is the American ICD-10-CM version of K75 - other international versions of ICD-10 K75 may differ. NAFLD is associated with excess risk of all-cause mortality, and its progression to nonalcoholic steatohepatitis (NASH) and fibrosis accounts for a growing proportion of cirrhosis and hepatocellular cancer and thus is a leading cause of liver transplant. Non-alcoholic steatohepatitis (NASH) refers to an advanced form of NAFLD, and it is characterized by the presence of. 6 ‘Other and unspecified cirrhosis of liver’. This is the American ICD-10-CM version of K70. 0 may differ. Nonalcoholic fatty liver disease is a spectrum of liver diseases composed of nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH). 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis ( NASH) ICD-10-CM Diagnosis Code K74. Search for: Translate. 5 million persons from 22 countries. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. Cochrane Database Syst. The code is valid during the current fiscal year for the. Background: The diagnosis of NASH needs a liver biopsy, an invasive procedure that is not frequently accepted by patients. 81 NASH code and liver biopsy); ICD-10 NASH (patients with an ICD-10 K75. Below are some of the ICD-10-CM Diagnosis codes that could potentially be assigned based on provider documentation. It is found in the 2024 version of the ICD-10 Clinical. Code Version: 2015 ICD-9-CM. K71 Toxic liver disease. Non-alcoholic steatohepatitis (NASH), the more progressive form of NAFLD, is particularly challenging to diagnose in the absence of histology. Long Description: Other chronic nonalcoholic liver disease. K70. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes. The existing literature regarding the relationship between OSA and nonalcoholic steatohepatitis (NASH) is conflicting. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. 5 (Cirrhosis of liver without mention of alcohol), 571. Tata laksana non-alcoholic fatty liver disesuaikan dengan etiologi metabolik yang mendasarinya. Alcoholic steatohepatitis and non-alcoholic steatohepatitis: Definitions, clinical signs and histological features. Quantitative results of 10 biochemicals in combination with age, gender, height, and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0. In 2013, NASH became the second leading. ICD-10 codes for esophageal varices with bleeding. 650-736-5555. Fatty replacement and damage to the hepatocytes not related to alcohol use. Showing 1-25: ICD-10-CM Diagnosis Code K70. Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of liver diseases: 25% of the population of European countries have signs of NAFLD, 10–20% of patients with steatosis. Figure. ICD-10-CM Diagnosis Codes. 8. Early identification and targeted treatment of patients with nonalcoholic. The liver makes and exports fat to other parts of the body. Doctors use your medical history, a physical exam, and tests to diagnose nonalcoholic fatty liver disease (NAFLD)—including nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). The reasons for lowlevel awareness are the relatively recent coining of the term “NASH” in 1980, the requirement of a liver biopsy for definitive diagnosis, the relatively indolent nature of the disease in most patients, and the lack of a consensus regarding histological. While also a condition of fat in the liver, those with nonalcoholic steatohepatitis have liver inflammation and, usually, liver cell damage as. Hepatic fibrosis, unspecified. NASH is characterized by steatosis accompanied by hepatocyte. A NAS of 5 or higher correlates with a diagnosis of NASH whereas a NAS of less than 3 is not consistent with this diagnosis. The prevalence of NAFLD in the United States is reported to be between 10% and 30% , and the pooled overall global prevalence of NAFLD diagnosed by imaging was estimated to be greater than 25% . 2174/1381612825666190117102111. A swollen belly ( ascites) Bruising and bleeding easily. logically into nonalcoholic fatty liver (NAFL) or non-alcoholic steatohepatitis (NASH; Table 2). [3] It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the. 9,10 Nonalcoholic steatohepatitis is also fuelingNon-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that affects approximately one-quarter of the global adult population, posing a significant threat to human health with wide-ranging social and economic implications. Incident HF was. Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. 2012 ICD-9-CM Diagnosis Code 571. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Nonalcoholic fatty liver; Non-alcoholic fatty liver; Nonalcoholic steatohepatitis; Portal fibrosis without cirrhosis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver) Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronicNonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver) Clinical Information. 6 became effective on October 1, 2023. A recent analysis of studies involving more than 8. Y. Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. ICD-10: K75. 69 - other international versions of ICD-10 K74. 8. Evidence of steatohepatitis included a steatohepatitis NLP affirmation. Overview Symptoms and Causes Diagnosis and Tests Management and Treatment Prevention Outlook / Prognosis. Fibrosis is the first stage of liver scarring. 0. 3), primary biliary. ICD-10-CM K75. The 2024 edition of ICD-10-CM K70. Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. Patients with T2D are at an increased risk of developing cirrhosis, liver failure, and hepatocellular carcinoma and. , Ste. 2 Alcoholic cirrhosis of liver convert 571. 8 (Other. Natural history of NAFLD. The 2024 edition of ICD-10-CM K71. NAFLD and NASH can be silent diseases with no symptoms at all or very mild symptoms such as tiredness and fatigue in early stages of the disease. 81: 571. 0Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver enzymes in both adults and children. 0 ‘Fatty (change of) liver, not elsewhere classified (non-alcoholic fatty liver disease)’. Steatosis and lobular inflammation are graded 0–3 based on severity, whereas ballooning is graded 0–2. It is widely known that alcohol use can cause liver damage, but other risk factors make it possible to develop liver disease even if you drink little to no alcohol. 85 versus 0. [2] Patients typically have a history of at least 10 years of heavy alcohol intake, typically 8-10 drinks per day. Alcoholic fatty liver. A silent disease with no symptoms or mild symptoms such as tiredness and fatigue in early stages. 0 - fatty liver degeneration, not classified elsewhere. clevelandclinic. This is the American ICD-10-CM version of K70. The 2024 edition of ICD-10-CM K74. 69 Nature Medicine (2023) There are no approved diagnostic biomarkers for at-risk non-alcoholic steatohepatitis (NASH), defined by the presence of NASH, high histological activity and fibrosis stage. The non-alcoholic steatohepatitis (NASH) market size is projected to reach $24. 401-421-3185. (ICD-9) codes. Two types of NAFLD are nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). g. In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. Liver Transplant Program. The condition is characterised by excessive hepatic fat accumulation and is directly associated with. Perakakis N, Polyzos SA, Yazdani A, et al. When using code K70. 9 may differ. As the burden of hepatitis C abates over the next decade, non-alcoholic fatty liver disease will become the major form of chronic liver disease in adults and children. 2024 ICD-10-CM Range K00-K95. Nonalcoholic steatohepatitis is strongly associated with overweight or obesity and the metabolic syndrome. Although, minor deposition of fat can occur in the liver of healthy adults, deposition of fat in at least 5% of hepatocytes is considered pathologic. Background. This is the American ICD-10-CM version of K74. 3). NASH is falls within the large, overarching theme of non-alcoholic fatty liver disease (NAFLD. 9 Inflammatory liver disease, unspecified;Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. This topic will review the treatment and prognosis of NAFLD. 0) of liver fibrosis (Metavir F0-F4), hepatic steatosis (0. Alcoholic fatty liver. Fatty replacement and damage to the hepatocytes not related to alcohol use. Steatohepatitis (also known as fatty liver disease) is a type of liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver (steato-, meaning "fat", hepatitis, meaning "inflammation of the liver"). ICD-9-CM 571. underlying liver disease, such as: nonalcoholic steatohepatitis (NASH) (. Alcoholic hepatitis ranges from mild and reversible to life threatening. ICD-10-CM 2023 Coding Guide™ from Unbound Medicine. 1 About 35% of patients with NASH develop progressive liver fibrosis. 2022 ICD-10-CM Diagnosis Code. 5, 571. 9 - other international versions of ICD-10 K70. doi: 10. 0 - other international versions of ICD-10 K70. Recent epidemiologic studies have shown that nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in the US, with an estimated prevalence of 34% in the general population (based on screening using liver proton magnetic resonance spectroscopy). 21037/atm-20-4354. The 2024 edition of ICD-10-CM K70. This is the American ICD-10-CM version of K70. You may feel tired or have pain in the upper right side of your abdomen, where your liver is. K76. K76 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. , 2022 ), accounting for 45. 1. Download references. Evidence of fibrosis included either an ICD-10 diagnosis code, a fibrosis NLP diseases (non-alcoholic steatohepatitis)’ and K76. 9 may differ. We assess the impact of having NAFLD on adverse clinical outcomes and all-cause mortality for people with CKD. Data collection period: 2012 ICD-9 code was used to identify NASH patients in the OSA and control group: Frequency: NASH (overall): 0. However, the prevalence and incidence of recorded NAFLD diagnoses in unselected real-world health-care records is unknown. Metabolic dysfunction–associated steatotic liver disease ( MASLD) is the name adopted in 2023 for the condition previously known as non-alcoholic fatty liver disease ( NAFLD ). Qingfu Zhu, # 1 Hengrui Li, # 1 Zheng Ao, 6 Hao Xu, 1 Jiaxin luo, 1 Connor Kaurich, 6 Rui Yang, 1 Pei-Wu Zhu, 7 Sui-Dan Chen, 8 Xiao-Dong Wang, 5 Liang-Jie Tang, 3 Gang Li, 3 Ou-Yang Huang, 3 Ming-Hua Zheng, 3, 4, 5 Hui-Ping Li, 2. 3, V11. ICD-10- AM, International Classi cation of Diseases, Tenth Revision, Australian Modi cation; NAFLD, non- alcoholic fatty liver disease; NASH, non- alcoholic steatohepatitis; NPV, negative predictive There has been an increased interest in non-alcoholic fatty liver disease (NAFLD), and its advanced stage, non-alcoholic steatohepatitis (NASH) because of their increasing impact on global health . 0 - other international versions of ICD-10 K74. 0-1. 10 - other international versions of ICD-10 K72. The Hospital Discharge Abstract Database (DAD) was used to. Background Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) frequently co-exist. Ask a Question. Healthcare Provider Information about Non-Alcoholic Steatohepatitis (NASH) NASH is a chronic liver disease characterized by liver cell injury (hepatocellular ballooning) and inflammation as a result of fatty accumulation (steatosis) seen in at least 5% of hepatocytes. K75. 1 that describes the diagnosis 'alcoholic hepatitis' in more detail. Nonalcoholic fatty liver disease. ICD 10 CM K75. 02: Hepatic fibrosis:. The severe form is called nonalcoholic steatohepatitis. 9 - other international versions of ICD-10 K75. 69 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 0-) ICD-10-CM Diagnosis. ICD-9-CM 571. 1 Up to one in four patients with NAFLD may have non-alcoholic steatohepatitis (NASH), which is associated with significant. 0Limitations. Lancet Gastroenterol. Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. Other chronic nonalcoholic liver disease. In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. Introduction. exclusions. K70. Jun 09, 2023. Pendekatan nonfarmakologi terdiri atas modifikasi gaya hidupNASH - Nonalcoholic steatohepatitis (442685003); Nonalcoholic steatohepatitis (442685003); Non-alcoholic steatohepatitis (442685003) Definition. In addition, the presence of NAFLD is. Chronic hepatic failure without coma. INTRODUCTION. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. alcoholic liver disease (. Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. Alcoholic fatty liver. Opsi terapi Non-alcoholic Fatty Liver Disease (NAFLD) dan Non-alcoholic Steatohepatitis (NASH) saat ini dapat menggunakan pendekatan farmakologi dan nonfarmakologi. Nonalcoholic steatohepatitis: Nonalcoholic steatohepatitis is one of the types of steatohepatitis. General weakness. 81. Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. 81 - Nonalcoholic steatohepatitis (NASH) is a topic covered in the ICD-10-CM. Weight loss for no clear reason. Liver Transplant Program. 9 million patients in 2030 (~1/3. 10 is a valid billable ICD-10 diagnosis code for Alcoholic hepatitis without ascites . Nonalcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease in the United States, afflicting an estimated 80 to 100 million Americans. This classification algorithm was superior to an algorithm using ICD-9 data alone with AUC of 0. Background: The diagnosis of NASH needs a liver biopsy, an invasive procedure that is not frequently accepted by patients. Non-invasive tests (Fibrosis-4 (FIB-4) index for liver fibrosis, NAFLD fibrosis score, enhanced liver fibrosis score and. Codes . FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. 81 is VALID for claim submission. Metabolic dysfunction-associated steatohepatitis (MASH) is the replacement term for NASH. ICD-10-CM Codes; ICD-10-PCS Codes; Legacy ICD-9-CM Codes; Indexes . 0. Bookshelf ID: NBK470243 PMID: 29262166. 0. 81 is a billable ICD code used to specify a diagnosis of nonalcoholic steatohepatitis (NASH). This is the first study using the ICD-10-CM code with a specific search code for NASH. It is the most severe form of metabolic dysfunction-associated steatotic. 0 - other international versions of ICD-10 K74. 2021 - New Code 2022 2023 2024 Billable/Specific Code. Nonalcoholic steatohepatitis (NASH) Show additional info Hide additional info. DRG Group #441-443 - Disorders of liver except malig, cirr, alc hepa with MCC.